Reduction of Cyclosporine-Induced Gingival Overgrowth Following a Change to Tacrolimus. A Case History Involving a Liver Transplant Patient
- 1 June 1998
- journal article
- case report
- Published by Wiley in The Journal of Periodontology
- Vol. 69 (6) , 729-732
- https://doi.org/10.1902/jop.1998.69.6.729
Abstract
During immunosuppression with cyclosporine, gingival overgrowth, a minor secondary effect, may appear in the first weeks of treatment. In certain cases it may affect the function and/or esthetic appearance in a manner intolerable to the patient. A new immunnosuppressive molecule, tacrolimus, presently used as a treatment of second choice to control acute corticoresistant rejection, may bring oral comfort to these patients, since it reduces gingival overgrowth to negligible levels.Keywords
This publication has 8 references indexed in Scilit:
- Two-year data from the European multicentre tacrolimus (F 06) liver studyTransplant International, 1996
- FK 506 rescue therapy for intractable liver allograft rejectionTransplant International, 1994
- TacrolimusDrugs, 1993
- Cyclosporine-induced gingival overgrowth: An ultrastructural stereologic studyOral Surgery, Oral Medicine, Oral Pathology, 1988
- Drugs and the periodontiumJournal of Clinical Periodontology, 1988
- Cyclosporin‐A‐Induced Gingival EnlargementThe Journal of Periodontology, 1987
- Severe Gingival Overgrowth Associated with Cyclosporine TherapyThe Journal of Periodontology, 1986
- Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapyOral Surgery, Oral Medicine, Oral Pathology, 1983